Ad is loading...
JMCRX
Price
$23.47
Change
+$0.33 (+1.43%)
Updated
Nov 22 closing price
VISVX
Price
$51.30
Change
+$0.69 (+1.36%)
Updated
Nov 22 closing price
Ad is loading...

JMCRX vs VISVX

Header iconJMCRX vs VISVX Comparison
Open Charts JMCRX vs VISVXBanner chart's image
James Micro Cap
Price$23.47
Change+$0.33 (+1.43%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$51.30
Change+$0.69 (+1.36%)
VolumeN/A
CapitalizationN/A
JMCRX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JMCRX vs. VISVX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMCRX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. JMCRX (30.3M). VISVX pays higher dividends than JMCRX: VISVX (1.90) vs JMCRX (0.60). JMCRX was incepted earlier than VISVX: JMCRX (14 years) vs VISVX (27 years). VISVX is a more actively managed with annual turnover of: 16.00 vs. JMCRX (5.00). VISVX has a lower initial minimum investment than JMCRX: VISVX (3000) vs JMCRX (10000). VISVX (30.04) and JMCRX (28.90) have marching annual gain over last year. VISVX return over 5 years is better than : 62.14 vs. JMCRX (46.28).
JMCRXVISVXJMCRX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years27 years-
Gain YTD14.26517.71281%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets30.3M57.6B0%
Annual Yield % from dividends0.601.9032%
Returns for 1 year28.9030.0496%
Returns for 3 years10.2816.9261%
Returns for 5 years46.2862.1474%
Returns for 10 years36.19109.8333%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFXT9.240.20
+2.21%
Enerflex Ltd
RVSN0.440.01
+1.60%
Rail Vision Ltd
CAG27.170.05
+0.18%
Conagra Brands
FULC2.97-0.02
-0.67%
Fulcrum Therapeutics
KYMR43.51-0.54
-1.23%
Kymera Therapeutics